Hyperdynamics (HDY) - NYSE Stock Hey guys, sorry I couldn't write this earlier but like I said if it's anything besides biotech and big pharm investments I usually don't talk about it on this site. Add that with oil stocks being very speculative (higher risk than biotechs IMO); I don't like to recommend stocks with such high risk. However, after receiving a lot of private messages I'll go ahead and fulfill the request by writing my analysis here. Before reading this, ...
I decided to talk about our MSCs earlier than I was planning for two reasons: 1. This Article today in ICells front pageiscovery key to halting nerve fibre damage in MS | Investor Stemcell 2. The Rabin 1st Quarter Call Tomorrow. First ... Please read the MS article above and the play to Fast Tracked whatever study they are doing with the FDA. And, I will take a gallon of Kool Aid and say that this Article is already obsolete. ACTC's MSC is at least 10x better than ...
Post 12 of 18, 18 posts in 18 months – Road to a million May Post Everyone, What is happening? Well a few things happened in April and the first few days of May. We signed up two more of the Top Eye Institutes in the United States, Bascom Palmer Eye Institute and Massachusetts eye and Ear has been approved for Clinical Trials. As the results come in, more and more of the Top Clinics in the country want to be involved. The Data Safety and Monitoring Board ...
1 Why Build the 2 Stem Cell Banks, Why the stronger focus on NPCs and MSCs? This will be a 3 part blog and it is a look forward on what is before ACTC in terms of revenue potential, product platforms, and its political/moral strategy. First, I think our Ethics Board has done a great job and is doing a great job. Second, I think that Vincent is doing a great job in the way he has positioned ACTC relative to the RPEs Vs. the Product Pipeline. This was foremost ...
Where Exactly are We (ACTC)? We are all investors here. Hard earned money all on the line. So, I reviewed ACTC's Presentation for the 3rd Time and this is where We are. Vincent is the point man for all the work that needs to get done. Rabin decides on the finance side. Vincent has a very good understanding of the stakes: synergy, pipeline acceleration, approval acceleration, 800 pound gorilla at the gate, Manufacturing, Sales and Distribution ...